Cargando…

Seromucinous component in endometrioid endometrial carcinoma as a histological predictor of prognosis

OBJECTIVE: In 2014 World Health Organization criteria, seromucinous carcinoma was defined as a new histological subtype in ovarian carcinomas, but “seromucinous carcinoma” was not defined in endometrial carcinomas. The aim of this study was to identify seromucinous carcinoma resembling ovarian serom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyamoto, Morikazu, Takano, Masashi, Aoyama, Tadashi, Soyama, Hiroaki, Yoshikawa, Tomoyuki, Tsuda, Hitoshi, Furuya, Kenichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823981/ https://www.ncbi.nlm.nih.gov/pubmed/29400013 http://dx.doi.org/10.3802/jgo.2018.29.e20

Ejemplares similares

Inhibition of autophagy protein LC3A as a therapeutic target in ovarian clear cell carcinomas
por: Miyamoto, Morikazu, et al.
Publicado: (2017)

Intraepithelial lymphocytes are indicators of better prognosis in surgically resected endometrioid-type endometrial carcinomas at early and advanced stages
por: Kono-Sato, Takako, et al.
Publicado: (2022)

DNA mismatch repair-related protein loss as a prognostic factor in endometrial cancers
por: Kato, Masafumi, et al.
Publicado: (2015)

Relation between Birth Weight and Intraoperative Hemorrhage during Cesarean Section in Pregnancy with Placenta Previa
por: Soyama, Hiroaki, et al.
Publicado: (2016)

Clear cell histology as a poor prognostic factor for advanced epithelial ovarian cancer: a single institutional case series through central pathologic review
por: Miyamoto, Morikazu, et al.
Publicado: (2013)

Psoas muscle index at the fifth lumbar vertebra as a predictor of survival in epithelial ovarian cancers
por: Yoshikawa, Tomoyuki, et al.
Publicado: (2021)

L1CAM Expression is Related to Non-Endometrioid Histology, and Prognostic for Poor Outcome in Endometrioid Endometrial Carcinoma
por: Geels, Yvette P., et al.
Publicado: (2016)

A Case of Endometrial Carcinosarcoma Containing Sertoliform Endometrioid Carcinoma Component
por: Munakata, Satoru, et al.
Publicado: (2021)

Pelvic seromucinous borderline tumor 26 years after ovarian seromucinous borderline tumor managed with post-treatment estrogen replacement therapy
por: Uehara, Takashi, et al.
Publicado: (2020)

Seromucinous hamartoma of inferior turbinate: A case report
por: Lee, Dong Hoon, et al.
Publicado: (2018)

Ovarian seromucinous carcinoma: an independent epithelial ovarian cancer?
por: Hu, Yi, et al.
Publicado: (2023)

Comparison of clinical behavior between mucinous ovarian carcinoma with infiltrative and expansile invasion and high-grade serous ovarian carcinoma: a retrospective analysis
por: Hada, Taira, et al.
Publicado: (2022)

Hypoxia and Angiogenesis in Endometrioid Endometrial Carcinogenesis
por: Horrée, Nicole, et al.
Publicado: (2007)

VEGF Immunoexpression in Endometrioid Endometrial Carcinomas
por: DROCAŞ, ILEANA, et al.
Publicado: (2022)

Snail Immunoexpression in Endometrioid Endometrial Carcinomas
por: FLORESCU, MIRELA MARINELA, et al.
Publicado: (2022)

Anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy
por: Okumura, Toshiyuki, et al.
Publicado: (2018)

Ovarian Seromucinous Tumors: Pathogenesis, Morphologic Spectrum, and Clinical Issues
por: Nagamine, Michiko, et al.
Publicado: (2020)

Seromucinous hamartoma of ethmoid sinus in pediatric patient (case report)
por: Alokby, Ghassan, et al.
Publicado: (2021)

Mutation Profiles of Ovarian Seromucinous Borderline Tumors in Japanese Patients
por: Sasamori, Hiroki, et al.
Publicado: (2022)

Survival and biomarker analysis for ovarian mucinous carcinoma according to invasive patterns: retrospective analysis and review literature
por: Hada, Taira, et al.
Publicado: (2021)

Clinicopathological Prognostic Parameters of Endometrioid Endometrial Carcinomas
por: DROCAŞ, ILEANA, et al.
Publicado: (2022)

An endonasal approach to the resection of a papillary seromucinous adenocarcinoma of the Eustacian tube
por: Glicksman, Jordan T, et al.
Publicado: (2013)

Ovarian Seromucinous Borderline Tumor and Clear Cell Carcinoma: An Unusual Combination
por: Nakamura, Eriko, et al.
Publicado: (2015)

A diagnostic challenge of seromucinous borderline tumor: A case report
por: Liu, Tingting, et al.
Publicado: (2019)

Role of serum microRNAs as biomarkers for endometriosis, endometrioid carcinoma of ovary & endometrioid endometrial cancer
por: Kumari, Priti, et al.
Publicado: (2022)

Rapid identification of endometrial hyperplasia and endometrial endometrioid cancer in young women
por: Kuai, Dan, et al.
Publicado: (2023)

Chorioamniotic membrane separation caused by the seromucinous collection from a placental chorioangioma
por: Eom, Hye Mi, et al.
Publicado: (2016)

Differentiation of Seromucinous Borderline Tumor from Serous Borderline Tumor on MR Imaging
por: Kurata, Yasuhisa, et al.
Publicado: (2017)

Second fertility preservation surgery for early relapse of seromucinous borderline ovarian tumors
por: Kanno, Motoko, et al.
Publicado: (2021)

Long-term survival of endometrioid endometrial cancer patients
por: Gottwald, Leszek, et al.
Publicado: (2010)

Tumor grade and chemotherapy response in endometrioid endometrial cancer
por: Davidson, Brittany A., et al.
Publicado: (2016)

Prognostic factors of synchronous endometrial and ovarian endometrioid carcinoma
por: Yoneoka, Yutaka, et al.
Publicado: (2018)

An integrated prediction model of recurrence in endometrial endometrioid cancers
por: Miller, Marina D, et al.
Publicado: (2019)

Extragonadal Giant Endometrial Cyst with Endometrioid Borderline Tumor
por: Yazawa, Hiroyuki, et al.
Publicado: (2019)

Endothelin-3 is epigenetically silenced in endometrioid endometrial cancer
por: Zmarzły, Nikola, et al.
Publicado: (2022)

Histological Grade of Endometrioid Endometrial Cancer and Relapse Risk Can Be Predicted with Machine Learning from Gene Expression Data
por: Gargya, Péter, et al.
Publicado: (2021)

The role of p16-cyclin D/CDK-pRb pathway in the tumorigenesis of endometrioid-type endometrial carcinoma
por: Tsuda, H, et al.
Publicado: (2000)

EZH2 inhibition in ARID1A mutated clear cell and endometrioid ovarian and endometrioid endometrial cancers
por: Alldredge, Jill K., et al.
Publicado: (2017)

Ovarian seromucinous tumors: clinicopathological features of 10 cases with a detailed review of the literature
por: Idrees, Romana, et al.
Publicado: (2021)

PAX2, PAX8, and PR are correlated with ovarian seromucinous borderline tumor with endometriosis
por: Yun, Bo Seong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sd7u4n35nmne7umhuldhltt44q